Skip to content
GLP-1 Family advanced

GLP-1 Agonist Neuroprotective Effects

Evidence for neuroprotective and neurorestorative effects of GLP-1 receptor agonists in neurodegenerative diseases.

By Encyclopeptide Editorial | 1 min read
GLP-1 neuroprotection Alzheimers Parkinsons neurodegeneration

Preclinical Evidence

Alzheimer’s Disease Models

  • Reduced amyloid-beta plaque deposition
  • Improved cognitive function
  • Reduced tau phosphorylation

Parkinson’s Disease Models

  • Improved motor function in MPTP models
  • Reduced dopaminergic neuron loss

Mechanisms of Neuroprotection

  1. Anti-inflammatory: Reduced microglial activation
  2. Anti-apoptotic: PI3K/Akt pathway activation
  3. Mitochondrial: Improved mitochondrial biogenesis
  4. Synaptic: Enhanced synaptic plasticity

Chemical Identity

PropertyValue
NameGLP-1 Agonist Neuroprotective Effects
CategoryGLP-1 Family

References

  1. Encyclopeptide Database. “GLP-1 Agonist Neuroprotective Effects” monograph. encyclopeptide.com.

Test Your Knowledge

Reinforce what you learned about GLP-1 Agonist Neuroprotective Effects with interactive quizzes on Wikipept.

Take a Quiz on Wikipept